Seer Inc (SEER)
2.42
+0.10
(+4.40%)
USD |
NASDAQ |
Nov 14, 16:00
2.42
0.00 (0.00%)
After-Hours: 19:53
Seer Revenue (Quarterly): 3.942M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.942M |
| June 30, 2024 | 3.026M |
| March 31, 2024 | 3.03M |
| December 31, 2023 | 4.18M |
| September 30, 2023 | 3.814M |
| June 30, 2023 | 3.47M |
| March 31, 2023 | 3.718M |
| Date | Value |
|---|---|
| December 31, 2022 | 3.861M |
| September 30, 2022 | 3.955M |
| June 30, 2022 | 3.571M |
| March 31, 2022 | 3.298M |
| December 31, 2021 | 3.032M |
| September 30, 2021 | 2.145M |
| June 30, 2021 | 1.217M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.217M
Minimum
Jun 2021
4.18M
Maximum
Dec 2023
3.304M
Average
3.520M
Median
Revenue (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 130.23M |
| Poseida Therapeutics Inc | 25.97M |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.05M |
| IGC Pharma Inc | 0.272M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.33M |
| Total Expenses (Quarterly) | 28.27M |
| EPS Diluted (Quarterly) | -0.35 |
| Enterprise Value | -110.92M |
| Gross Profit Margin (Quarterly) | 46.88% |
| Profit Margin (Quarterly) | -541.0% |
| Earnings Yield | -53.72% |
| Normalized Earnings Yield | -53.72 |